Skip to main content
SpringerLink
Log in

Human Tumor Screening

  • Chapter
Anticancer Drug Development Guide

Part of the book series: Cancer Drug Discovery and Development ((CDD&D))

Abstract

In 1995, an estimated 1.25 million patients are diagnosed with cancer in the US and the number of predicted cancer deaths is in excess of 540,000 (1). Similar incidences and death rates for the most important cancers are reported from other industrialized Western countries. Most patients diagnosed with cancer will receive one or more chemotherapy regimens during the course of their disease. Retrospective and prospective clinical trials have improved the likelihood of response in individual patients and have been pivotal in the development of curative regimens for patients with a variety of malignancies. These major advances include patients with childhood tumors, testicular cancer, and some types of leukemias and malignant lymphomas. The empiric clinical approach has also led to the development of successful adjuvant therapies for patients with breast cancer, osteogenic sarcomas, and colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA 1995; 1: 8–30.

    Google Scholar 

  2. Von Hoff DD, Sandbach JF, Clark GM, Turner JN, Forseth BF, Piccart MJ, Colombo N, Muggia FM. Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician. J Natl Cancer Inst 1990; 82: 110–116.

    Article  Google Scholar 

  3. Perez E, Eckardt J, Hilsenbeck S, Rothenberg M, Degen D, Von Hoff DD. Activity of cytotoxic agents against non-small cell lung cancer specimens using a human tumor cloning assay. Proc Am Assoc Cancer Res 1994; 35: 203.

    Google Scholar 

  4. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977; 197: 461–463.

    Article  PubMed  CAS  Google Scholar 

  5. Buick RN, Pollack MN. Perspectives on clonogenic tumor cells, stem cells, and oncogenes. Cancer Res 1984; 44: 4909–4918.

    PubMed  CAS  Google Scholar 

  6. Mackillop WJ, Ciampi A, Till JE, Buick RN. A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J Natl Cancer Inst 1983; 70: 9–16.

    PubMed  CAS  Google Scholar 

  7. Potten CS, Schofield R, Lajtha LG. A comparison of cell replacement in bone marrow, testis and three regions of surface epithelium. Biochim Biophys Acta 1979; 560: 281–299.

    PubMed  CAS  Google Scholar 

  8. Hamburger AW, Salmon SE. Primary bioassay of human myeloma stem cells. J Clin Invest 1977; 60: 846–854.

    Article  PubMed  CAS  Google Scholar 

  9. Salmon SF, Hamburger AW, Soehnlen B, Durie BGM, Alberts DS, Moon TE. Quantitation if differential sensitivity of human tumor stem cells to anticancer drugs. New Engl J Med 1978; 298: 1321–1327.

    Article  PubMed  CAS  Google Scholar 

  10. Tanigawa N, Kern DH, Hikasa Y, Morton DL. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res 1982; 42: 2159–2164.

    PubMed  CAS  Google Scholar 

  11. Von Hoff DD, Forseth BJ, Huong M, Buchok JB, Lathan B. Improved plating efficiencies for human tumors cloned in capillary tubes versus Petri dishes. Cancer Res 1986; 46: 4012–4017.

    Google Scholar 

  12. Hanauske A-R, Hanauske U, Von Hoff DD. The human tumor cloning assay in cancer research and therapy. Curr Probl Cancer 1985; 9: 1–50.

    Article  PubMed  CAS  Google Scholar 

  13. Kern DH, Weisenthal LM. Highly specific prediction of antineoplastic drug resistance with an in vitro assay using suprapharmacologic drug exposures. J Natl Cancer Inst 1990; 82: 582–588.

    Article  PubMed  CAS  Google Scholar 

  14. Courtenay D, Selby PJ, Smith IE, Mills J, Peckham MJ. Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer 1978; 38: 77–81.

    Article  PubMed  CAS  Google Scholar 

  15. Maurer HR, Ali-Osman F. Tumor stem cell cloning in agar-containing capillaries. Naturwiss en Schaften 1981; 68: 381–383.

    Article  CAS  Google Scholar 

  16. Lathan B, Kerkhoff K, Scheithauer W, Von Hoff DD, Diehl V. Homogeneous growth of tumor cell colonies in agar containing glass capillaries. Anticancer Res 1989; 9: 1897–1902.

    PubMed  CAS  Google Scholar 

  17. Hanauske U, Hanauske A-R, Marshall MH, Muggia VA, Von Hoff DD. Biphasic effects of vanadium salts on in vitro tumor colony growth. Int J Cell Cloning 1987; 5: 170–178.

    Article  PubMed  CAS  Google Scholar 

  18. Von Hoff DD. He’s not going to talk about in vitro predictive assays again, is he? J Natl Cancer Inst 1990; 82: 96–101.

    Article  Google Scholar 

  19. Osborne CK, Yochnowitz MG, Knight WA. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 1980; 46: 2884–2888.

    Article  PubMed  CAS  Google Scholar 

  20. Von Hoff DD, Kronmal R, Salmon SE, Turner J, Green JB, Bonorris JS, Moorhead EL, Hynes HE, Pugh RE, Belt RJ, Alberts DS. A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer. Cancer 1991; 67: 20–27.

    Article  Google Scholar 

  21. Von Hoff DD. In vitro predictive testing: the sulfonamide era. Int J Cell Cloning 1987; 5: 179–190.

    Article  Google Scholar 

  22. Weisenthal LM, Dill PL, Kurnick NB, Lippmann ME. Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res 1983; 43: 258–264.

    PubMed  CAS  Google Scholar 

  23. Von Hoff DD. Human tumor cloning assays: applications in clinical oncology and new antineo-plastic agent development. Cancer Metastasis Rev 1988; 7: 357–371.

    Article  Google Scholar 

  24. Salmon SE, Meyskens FL Jr, Alberts DS, Soehnlen B, Young L. New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay. Cancer Treatment Rep 1981; 65: 1–12.

    CAS  Google Scholar 

  25. Neumann HA, Herrmann DB, Boerner D. Inhibition of human tumor colony formation by the new alkyl lysophospholipid ilmofosine. J Natl Cancer Inst 1987; 78: 1087–1093.

    PubMed  CAS  Google Scholar 

  26. Von Hoff DD, Clark GM, Weiss GR, Marshall MH, Buchok JB, Knight WA III, LeMaistre CF. Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens. J Clin Oncol 1986; 4: 1827–1834.

    Google Scholar 

  27. Arteaga CL, Kisner DL, Goodman A, Von Hoff DD. Elliptinium, a DNA intercalating agent with broad antitumor activity in a human tumor cloning system. Eur J Cancer Clin Oncol 1987; 11: 1621–1626.

    Article  Google Scholar 

  28. Hanauske A-R, Degen D, Marshall MH, Hilsenbeck SG, McPhillips JJ, Von Hoff DD. Pre-clinical activity of ilmofosine against human tumor colony forming units in vitro. Anti-Cancer Drugs 1992; 3: 43–46.

    Article  PubMed  CAS  Google Scholar 

  29. Hanauske A-R, Degen D, Marshall MM, Hilsenbeck SG, Grindey GB, Von Hoff DD. Activity of 2 ′,22′-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units. Anti-Cancer Drugs 1992; 3: 143–146.

    Article  PubMed  CAS  Google Scholar 

  30. Hanauske A-R, Degen D, Hilsenbeck SG, Bissery MC, Von Hoff DD. Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anti-Cancer Drugs 1992; 3: 121–124.

    Article  PubMed  CAS  Google Scholar 

  31. Hanauske A-R, Ross M, Degen D, Hilsenbeck SG, Von Hoff DD. In vitro activity of the benzo- triazene dioxide SR 4233 against human tumour colony-forming units. Eur J Cancer 1993; 29A: 423–425.

    Article  Google Scholar 

  32. Marshall MV, Marshall MH, Degen DR, Roodman GD, Kuhn JG, Ross ME, Von Hoff DD. In vitro cytotoxicity of Hepsulfam against human tumor cell lines and primary human tumor colony forming units. Stem Cells 1993; 11: 62–69.

    Article  PubMed  CAS  Google Scholar 

  33. Vogel M, Hilsenbeck SG, Depenbrock H, Danhauser-Riedl S, Block T, Nekarda H, Fellbaum C, Aapro MS, Bissery MC, Rastetter J, Hanauske A-R. Preclinical activity of Taxotere (RP56976, NSC 628503) against freshly explanted clonogenic human tumour cells: Comparison with Taxol and conventional antineoplastic agents. Eur J Cancer 1993; 29A: 2009–2014.

    Article  Google Scholar 

  34. Lathan B, Von Hoff DD, Clark GM. Comparison of in vitro prediction and clinical outcome for two anthracene derivatives: mitoxantrone and bisantrene. In: Salmon SE, Trent JM, eds. Human Tumor Cloning. New York: Grune & Stratton. 1984: 607–619.

    Google Scholar 

  35. Lathan B, Von Hoff DD, Melink TJ, Kisner DL. Screening of Phase I drugs to pinpoint areas of emphasis in Phase II studies. In: Salmon SE, Trent JM, eds. Human Tumor Cloning. New York: Grune & Stratton. 1984: 669.

    Google Scholar 

  36. Hamburger AW, Lurie KA, Condon ME. Stimulation of anchorage-independent growth of human tumor cells by interleukin 1. Cancer Res 1987; 47: 5612–5615.

    PubMed  CAS  Google Scholar 

  37. Joraschkewitz M, Depenbrock H, Freund M, Erdmann G, Meyer H-J, DeRiese W, Neukam DF, Hanauske U, Krumwieh M, Poliwoda H, Hanauske A-R. Effects of cytokines on in vitro colony formation of primary human tumour specimens. Eur J Cancer 1990; 26: 1070–1074.

    Article  PubMed  CAS  Google Scholar 

  38. Hanauske A-R, Degen D, Marshall MH, Hilsenbeck SG, Banks P, Stuckey J, Leahy M, Von Hoff DD. Effects of recombinant human interleukin-la on clonogenic growth of primary human tumors in vitro. J Immunother 1992; 11: 155–158.

    Article  PubMed  CAS  Google Scholar 

  39. Hanauske A-R, DeRiese W, Joraschekewitz M, Freund M, Poliwoda H. Effects of cytokines on clonogenic growth of primary renal cancer cells: An in vitro Phase II study. Onkologie 1992; 15: 147–150.

    Article  Google Scholar 

  40. Bauer E, Danhauser-Riedl S, DeRiese W, Raab H-R, Sandner S, Meyer H-J, Neukam D, Hanauske U, Freund M, Poliwoda H, Rastetter J, Hanauske A-R. Effects of recombinant human erythropoietin on clonogenic growth of primary human tumour specimens in vitro. Eur J Cancer 1992; 28A: 1769.

    Article  Google Scholar 

  41. Yanagawa E, Nishiyama M, Saeki T, Kim R, Jinushi K, Kirihara Y, Takagami S, Niimoto M, Hattori T. Chemosensitivity tests in colorectal cancer patients. Jpn J Surg 1989; 19: 432–438.

    Article  PubMed  CAS  Google Scholar 

  42. Nishiyama M, Takagami S, Kirihara Y, Saeki T, Niimi K, Nosoh Y, Hirabayashi N, Niimoto M, Hattori T. The indications of chemosensitivity tests against various anticancer agents. Jpn J Surg 1988; 18: 647–652.

    Article  PubMed  CAS  Google Scholar 

  43. Von Hoff DD. In vitro predictive testing: the sulfonamide era. Int J Cell Cloning 1987; 5: 179–190.

    Article  Google Scholar 

  44. Sanfilippo O, Silvestrini R, Zaffaroni N, Piva L, Pizzocaro G. Application of an in vitro anti- metabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity. Cancer 1986; 58: 1441–1447.

    Article  PubMed  CAS  Google Scholar 

  45. Leone LA, Meitner PA, Myers TJ, Grace WR, Gajewski WH, Fingert HJ, Rotman B. Pre-dictive value of the fluorescent cytoprint assay (FCA): A retrospective correlation study of in vitro chemosensitivity and individual responses to chemotherapy. Cell Immunol 1991; 8: 1–13.

    Google Scholar 

  46. Weisenthal LM, Marsden JA, Dill PL, Macaluso CK. A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 1983; 43: 749–757.

    PubMed  CAS  Google Scholar 

  47. Koechli OR, Avner BP, Sevin B-U, Avner B, Perras JP, Robinson DS, Averette HE. Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: A report on the first results. J Surg Oncol 1993; 54: 119–125.

    Article  PubMed  CAS  Google Scholar 

  48. Furukawa T, Kubota T, Suto A, Takahara T, Yamaguchi H, Takeuchi T, Kase S, Kodaira S, Ishibiki K, Kitajima M. Clinical usefulness of chemosensitivity testing using the MTT assay. J Surg Oncol 1991; 48: 188–193.

    Article  PubMed  CAS  Google Scholar 

  49. Bodgen AE, Cobb WR, Lepage DJ, Haskell PM, Gulkin TA, Ward A, Kelton DE, Esber HJ. Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: Six-day subrenal capsule assay. Cancer 1981; 48: 10–20.

    Article  Google Scholar 

  50. Bellet RE, Danna V, Mastrangelo MJ, Berd D. Evaluation of a “nude” mouse-human tumor panel as a predictive secondary screen for cancer chemotherapy. J Natl Cancer Inst 1976; 63: 1185–1188.

    Google Scholar 

Download references

Authors
  1. Axel-R. Hanauske MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan G. Hilsenbeck PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel D. Von Hoff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dana-Farber Cancer Institute, Boston, MA, USA

    Beverly A. Teicher

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hanauske, AR., Hilsenbeck, S.G., Von Hoff, D.D. (1997). Human Tumor Screening. In: Teicher, B.A. (eds) Anticancer Drug Development Guide. Cancer Drug Discovery and Development. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4615-8152-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-8152-9_3

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4615-8154-3

  • Online ISBN: 978-1-4615-8152-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation